Evidence map›Paper›PMID 26089984›Full record

ArticleBiotechnology for biofuels2015

Developing a mesophilic co-culture for direct conversion of cellulose to butanol in consolidated bioprocess.

Zhenyu Wang, Guangli Cao, Ju Zheng, Defeng Fu, Jinzhu Song, Junzheng Zhang, Lei Zhao, Qian Yang

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Advances and Applications ofFrontiers in microbiology · 2020
    Review
  7. Review
  8. Production of butanol from biomass: recent advances and future prospects.Environmental science and pollution research international · 2019
    Review
  9. Review
  10. Unique genetic cassettes in aScience advances · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhenyu Wang *School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Guangli Cao *School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Ju ZhengSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Defeng FuSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Jinzhu SongSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Junzheng ZhangSchool of Food Science and Engineering, Harbin Institute of Technology, Harbin, 150090 China.
Lei ZhaoState Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, 150090 China.
Qian YangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001 China.
Harbin Institute of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsolidated bioprocessing (CBP) of butanol production from cellulosic biomass is a promising strategy for cost saving compared to other processes featuring dedicated cellulase production. CBP requires microbial strains capable of hydrolyzing biomass with enzymes produced on its own with high rate and high conversion and simultaneously produce a desired product at high yield. However, current reported butanol-producing candidates are unable to utilize cellulose as a sole carbon source and energy source. Consequently, developing a co-culture system using different microorganisms by taking advantage of their specific metabolic capacities to produce butanol directly from cellulose in consolidated bioprocess is of great interest.

resultsThis study was mainly undertaken to find complementary organisms to the butanol producer that allow simultaneous saccharification and fermentation of cellulose to butanol in their co-culture under mesophilic condition. Accordingly, a highly efficient and stable consortium N3 on cellulose degradation was first developed by multiple subcultures. Subsequently, the functional microorganisms with 16S rRNA sequences identical to the denaturing gradient gel electrophoresis (DGGE) profile were isolated from consortium N3. The isolate Clostridium celevecrescens N3-2 exhibited higher cellulose-degrading capability was thus chosen as the partner strain for butanol production with Clostridium acetobutylicum ATCC824. Meanwhile, the established stable consortium N3 was also investigated to produce butanol by co-culturing with C. acetobutylicum ATCC824. Butanol was produced from cellulose when C. acetobutylicum ATCC824 was co-cultured with either consortium N3 or C. celevecrescens N3-2. Co-culturing C. acetobutylicum ATCC824 with the stable consortium N3 resulted in a relatively higher butanol concentration, 3.73 g/L, and higher production yield, 0.145 g/g of glucose equivalent.

conclusionsThe newly isolated microbial consortium N3 and strain C. celevecrescens N3-2 displayed effective degradation of cellulose and produced considerable amounts of butanol when they were co-cultured with C. acetobutylicum ATCC824. This is the first report of application of co-culture to produce butanol directly from cellulose under mesophilic condition. Our results indicated that co-culture of mesophilic cellulolytic microbe and butanol-producing clostridia provides a technically feasible and more simplified way for producing butanol directly from cellulose.

Indexed as

BiobutanolCelluloseCo-cultureConsolidated bioprocessingConversion

Identifiers

PMID26089984
PMCPMC4471926
OpenAlexW1869249572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.